Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma

• Avirup Guha,
• Lai Wei,
• Sumithira Vasu,
• Daniel Addison,
• Jonathan E Brammer,
• Zachary Braunstein,
• Aashish Katapadi,
• Kyle Porter,
• Michael Biersmith,
• Vedat O Yildiz,
• Sakima A Smith,
• Benjamin Buck,
• Devin Haddad,
• Richard Gumina,
• Basem M William,
• Sam Penza,
• Ayman Saad,
• Nathan Denlinger,
• Ajay Vallakati,
• Ragavendra Baliga,
• Raymond Benza,
• Philip Binkley,
• Mason Mocarski,
• Steven M Devine,
• Samantha Jaglowski

Affiliations

Avirup Guha

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Lai Wei

Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Sumithira Vasu

Bone Marrow Transplantation and Cellular Therapies Program, Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, Ohio, USA

Daniel Addison

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Jonathan E Brammer

Bone Marrow Transplantation and Cellular Therapies Program, Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, Ohio, USA

Zachary Braunstein

Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Aashish Katapadi

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Kyle Porter

Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Michael Biersmith

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Vedat O Yildiz

Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Sakima A Smith

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Benjamin Buck

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Devin Haddad

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Richard Gumina

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Basem M William

Bone Marrow Transplantation and Cellular Therapies Program, Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, Ohio, USA

Sam Penza

Bone Marrow Transplantation and Cellular Therapies Program, Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, Ohio, USA

Ayman Saad

Bone Marrow Transplantation and Cellular Therapies Program, Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, Ohio, USA

Nathan Denlinger

Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, Ohio, USA

Ajay Vallakati

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Ragavendra Baliga

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Raymond Benza

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Philip Binkley

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Mason Mocarski

Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Steven M Devine

National Marrow Donor Program, Minneapolis, Minnesota, USA

Samantha Jaglowski

Bone Marrow Transplantation and Cellular Therapies Program, Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, Ohio, USA